Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
Titel:
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
Auteur:
O'Riordan, William Cardenas, Carrie Shin, Elliot Sirbu, Alissa Garrity-Ryan, Lynne Das, Anita F Eckburg, Paul B Manley, Amy Steenbergen, Judith N Tzanis, Evan McGovern, Paul C Loh, Evan